Position in DXCM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,026,599
+$3,002,116 QoQ
Shares Held
74,634
+131.5% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#273
of 966 holders
Holding Since
Mar 2023
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DXCM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Vinva Investment Management Ltd holds $152,478,853 across 8 Medical Devices names. DXCM ranks #5 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PODD |
Insulet Corp
|
430,460 | $65,537,535 | |
| 2 | MDT |
Medtronic plc
|
487,011 | $38,098,870 | |
| 3 | SYK |
Stryker Corp
|
76,411 | $24,057,239 | |
| 4 | BSX |
Boston Scientific Corp
|
292,684 | $12,491,753 | |
| 5 | DXCM |
Dexcom Inc
This page
|
74,634 | $5,026,599 | |
| 6 | ABT |
Abbott Laboratories
|
38,098 | $3,457,012 | |
| 7 | STE |
STERIS plc
|
14,412 | $3,034,734 | |
| 8 | ENOV |
Enovis CORP
|
37,445 | $775,111 |
All Filings in DXCM
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,026,599 | 74,634 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,024,483 | 32,237 | Shares | Sole | 2026-05-14 | |
| 2025-06-30 | $610,506 | 6,994 | Shares | Sole | 2025-08-13 | |
| 2024-12-31 | $1,027,108 | 13,207 | Shares | Sole | 2025-02-11 | |
| 2024-06-30 | $1,239,016 | 10,928 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $2,023,355 | 14,588 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $941,594 | 7,588 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $978,903 | 10,492 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,651,482 | 12,851 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,222,910 | 10,526 | Shares | Sole | 2023-05-11 | |
| No filing history on record for this holder in this stock. | ||||||